Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-013362
Filing Date
2024-02-09
Accepted
2024-02-09 17:00:27
Documents
1
Period of Report
2023-07-10

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 4171
  Complete submission text file 0000950170-24-013362.txt   5610
Mailing Address MEDAREX 707 STATE ROAD PRINCETON NJ 08540
Business Address
SCHADE CHRISTIAN S (Reporting) CIK: 0001214496 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40657 | Film No.: 24615913

Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)